AngioDynamics, Inc. (ANGO)Healthcare | Medical Instruments & Supplies | Latham, United States | NasdaqGS
15.85 USD
+0.07
(0.444%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 15.85 |
Hot Take ↕ | Aug. 22, 2026, 4:56 a.m. EDT
The investment case here is fundamentally broken despite the recent price rally. While revenue grew 8% recently, the company is hemorrhaging cash with negative operating margins (-6.5%) and a massive loss in equity value (-20.8% ROE). The balance sheet is fragile, trading at nearly 4x book value despite generating no earnings, which makes the high P/S ratio a trap rather than a growth premium. The multi-year price trajectory confirms this deterioration, with the stock down 43.6% over the last nine years, even though the latest annual gain was positive; this suggests the market is pricing in a return to losses rather than a continuation of the recent bounce. Short-term, the stock is technically neutral. It has bounced off its 200-day average, but the lack of earnings support and the heavy put option positioning suggest this rally lacks a sustainable floor. The statistical forecast offers no help, showing a weak lean upward with low confidence. There is no dividend to provide a safety net. This is a speculative vehicle for traders betting on a turnaround, but for investors, the combination of persistent losses, negative free cash flow relative to operations, and a history of structural decline warrants avoidance. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.159508 |
| AutoARIMA | 0.170444 |
| MSTL | 0.171445 |
| AutoETS | 0.171448 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 6.54 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.280 |
| Excess Kurtosis | -0.91 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 6.414 |
| Revenue per Share | 7.71 |
| Market Cap | 655,118,336 |
| Forward P/E | -352.22 |
| Beta | 0.32 |
| Profit Margins | -11.48% |
| Website | https://www.angiodynamics.com |
As of Aug. 22, 2026, 4:56 a.m. EDT: Speculators are positioning defensively with heavy open interest in out-of-the-money puts (strikes 10.0 and 12.5) expiring in early 2027, suggesting a fear of further downside. Conversely, there is notable volume in deep out-of-the-money calls (25.0 strike) for January 2027, indicating asymmetric bets on a potential recovery or catalyst-driven surge, though the immediate term shows low implied volatility and mixed positioning.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.50860417 |
| Address1 | 14 Plaza Drive |
| All Time High | 32.0 |
| All Time Low | 5.26 |
| Ask | 15.85 |
| Ask Size | 1 |
| Audit Risk | 7 |
| Average Daily Volume10 Day | 258,390 |
| Average Daily Volume3 Month | 446,198 |
| Average Volume | 446,198 |
| Average Volume10Days | 258,390 |
| Beta | 0.318 |
| Bid | 11.4 |
| Bid Size | 2 |
| Board Risk | 2 |
| Book Value | 4.096 |
| City | Latham |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 3 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 15.85 |
| Current Ratio | 2.187 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 15.97 |
| Day Low | 15.68 |
| Debt To Equity | 6.414 |
| Display Name | AngioDynamics |
| Earnings Call Timestamp End | 1,784,030,400 |
| Earnings Call Timestamp Start | 1,784,030,400 |
| Earnings Timestamp | 1,784,032,200 |
| Earnings Timestamp End | 1,790,857,800 |
| Earnings Timestamp Start | 1,790,857,800 |
| Ebitda | 188,000 |
| Ebitda Margins | 0.00059 |
| Enterprise To Ebitda | 3,256.438 |
| Enterprise To Revenue | 1.912 |
| Enterprise Value | 612,210,368 |
| Eps Current Year | -0.26667 |
| Eps Forward | -0.045 |
| Eps Trailing Twelve Months | -0.88 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 14.2352 |
| Fifty Day Average Change | 1.6148005 |
| Fifty Day Average Change Percent | 0.113437146 |
| Fifty Two Week Change Percent | 50.860416 |
| Fifty Two Week High | 16.29 |
| Fifty Two Week High Change | -0.44000053 |
| Fifty Two Week High Change Percent | -0.027010467 |
| Fifty Two Week Low | 9.39 |
| Fifty Two Week Low Change | 6.46 |
| Fifty Two Week Low Change Percent | 0.6879659 |
| Fifty Two Week Range | 9.39 - 16.29 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,086,096,600,000 |
| Float Shares | 31,787,914 |
| Forward Eps | -0.045 |
| Forward P E | -352.22223 |
| Free Cashflow | 21,770,250 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 632 |
| Fullday Change | 0.0700006 |
| Fullday Change Percent | 0.443604 |
| Fullday Price | 15.85 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.54624003 |
| Gross Profits | 174,892,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.12657 |
| Held Percent Institutions | 0.94105005 |
| Implied Shares Outstanding | 41,332,389 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,780,185,600 |
| Long Business Summary | AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York. |
| Long Name | AngioDynamics, Inc. |
| Market | us_market |
| Market Cap | 655,118,336 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_4803544 |
| Most Recent Quarter | 1,780,185,600 |
| Net Income To Common | -36,742,000 |
| Next Fiscal Year End | 1,811,721,600 |
| Non Diluted Market Cap | 652,225,098 |
| Number Of Analyst Opinions | 4 |
| Open | 15.88 |
| Operating Cashflow | 3,089,000 |
| Operating Margins | -0.06524 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.41 |
| Phone | 518 795 1400 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 15.85 |
| Post Market Time | 1,787,959,805 |
| Previous Close | 15.78 |
| Price Eps Current Year | -59.43676 |
| Price Hint | 2 |
| Price To Book | 3.869629 |
| Price To Sales Trailing12 Months | 2.046132 |
| Profit Margins | -0.11476 |
| Quick Ratio | 1.37 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0700006 |
| Regular Market Change Percent | 0.443604 |
| Regular Market Day High | 15.97 |
| Regular Market Day Low | 15.68 |
| Regular Market Day Range | 15.68 - 15.97 |
| Regular Market Open | 15.88 |
| Regular Market Previous Close | 15.78 |
| Regular Market Price | 15.85 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 200,736 |
| Return On Assets | -0.05131 |
| Return On Equity | -0.2077 |
| Revenue Growth | 0.08 |
| Revenue Per Share | 7.71 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 41,332,389 |
| Shares Percent Shares Out | 0.0327 |
| Shares Short | 1,353,475 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 1,315,694 |
| Short Name | AngioDynamics, Inc. |
| Short Percent Of Float | 0.0348 |
| Short Ratio | 2.24 |
| Source Interval | 15 |
| State | NY |
| Symbol | ANGO |
| Target High Price | 24.0 |
| Target Low Price | 17.0 |
| Target Mean Price | 20.0 |
| Target Median Price | 19.5 |
| Total Cash | 53,864,000 |
| Total Cash Per Share | 1.303 |
| Total Debt | 10,956,000 |
| Total Revenue | 320,174,016 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.88 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 12.12835 |
| Two Hundred Day Average Change | 3.7216501 |
| Two Hundred Day Average Change Percent | 0.30685544 |
| Type Disp | Equity |
| Volume | 200,736 |
| Website | https://www.angiodynamics.com |
| Zip | 12,110 |